Shunsuke Tano Selected Research

Equilibrative Nucleoside Transporter 1

5/2016

Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoing Gemcitabine-Based Chemoradiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shunsuke Tano Research Topics

Disease

1	Pancreatitis 04/2023
1	Adenocarcinoma 05/2016
1	Hemorrhage 02/2015
1	Neoplasms (Cancer) 02/2015
1	Atrophy 01/2015
1	Stomach Neoplasms (Stomach Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

1	Diclofenac (SR 38)FDA LinkGeneric 04/2023
1	Ringer's SolutionIBA 04/2023
1	Gemcitabine FDA Link 05/2016
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 05/2016
1	Equilibrative Nucleoside Transporter 1IBA 05/2016
1	Hemostatics (Antihemorrhagics)IBA 02/2015
1	ORALIT (ORS)IBA 02/2015
1	Capsules (Microcapsules)IBA 01/2015

Therapy/Procedure

2	Therapeutics 02/2015 - 01/2012
1	Chemoradiotherapy 05/2016